QDEL

#2351
QuidelOrtho Corporation Common Stock
17.3200 USD
+7.71%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
17.3200
17.3200
Rango anual
13.7000
35.5750
Cambio diario
+7.71%
Variación mensual
-0.17%
Variación en los últimos 6 meses
-43.23%
Cambio anual
-43.23%
Cierres anteriores
16.0800
Abrir
17.3200
Bid
Ask
Mínimo
17.3200
High
17.3200
Volumen
122
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.1792 B
  • Employee 6 500
  • Founded 1979
  • CEO Douglas C Bryant
  • Website www.quidelortho.com
  • Headquarter California, United States
  • FIGI BBG017TGV7M2
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.76
Relación precio/flujo de caja
0.73

QuidelOrtho Corporation

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

Noticias